ATOS
Price
$0.79
Change
+$0.02 (+2.60%)
Updated
Sep 5 closing price
Capitalization
101.79M
72 days until earnings call
NRIX
Price
$9.91
Change
+$0.79 (+8.66%)
Updated
Sep 5 closing price
Capitalization
757.61M
33 days until earnings call
Interact to see
Advertisement

ATOS vs NRIX

Header iconATOS vs NRIX Comparison
Open Charts ATOS vs NRIXBanner chart's image
Atossa Therapeutics
Price$0.79
Change+$0.02 (+2.60%)
Volume$558.87K
Capitalization101.79M
Nurix Therapeutics
Price$9.91
Change+$0.79 (+8.66%)
Volume$831.91K
Capitalization757.61M
ATOS vs NRIX Comparison Chart in %
Loading...
ATOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NRIX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ATOS vs. NRIX commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATOS is a Hold and NRIX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (ATOS: $0.79 vs. NRIX: $9.91)
Brand notoriety: ATOS and NRIX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ATOS: 62% vs. NRIX: 99%
Market capitalization -- ATOS: $101.79M vs. NRIX: $757.61M
ATOS [@Biotechnology] is valued at $101.79M. NRIX’s [@Biotechnology] market capitalization is $757.61M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATOS’s FA Score shows that 1 FA rating(s) are green whileNRIX’s FA Score has 1 green FA rating(s).

  • ATOS’s FA Score: 1 green, 4 red.
  • NRIX’s FA Score: 1 green, 4 red.
According to our system of comparison, ATOS is a better buy in the long-term than NRIX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATOS’s TA Score shows that 3 TA indicator(s) are bullish while NRIX’s TA Score has 6 bullish TA indicator(s).

  • ATOS’s TA Score: 3 bullish, 5 bearish.
  • NRIX’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, NRIX is a better buy in the short-term than ATOS.

Price Growth

ATOS (@Biotechnology) experienced а +3.29% price change this week, while NRIX (@Biotechnology) price change was +6.10% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.52%. For the same industry, the average monthly price growth was +14.52%, and the average quarterly price growth was +33.01%.

Reported Earning Dates

ATOS is expected to report earnings on Nov 17, 2025.

NRIX is expected to report earnings on Oct 09, 2025.

Industries' Descriptions

@Biotechnology (+2.52% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NRIX($758M) has a higher market cap than ATOS($102M). ATOS YTD gains are higher at: -16.534 vs. NRIX (-47.399). ATOS has higher annual earnings (EBITDA): -29.97M vs. NRIX (-212.78M). NRIX has more cash in the bank: 486M vs. ATOS (57.9M). ATOS has less debt than NRIX: ATOS (0) vs NRIX (51.9M). NRIX has higher revenues than ATOS: NRIX (88.4M) vs ATOS (0).
ATOSNRIXATOS / NRIX
Capitalization102M758M13%
EBITDA-29.97M-212.78M14%
Gain YTD-16.534-47.39935%
P/E RatioN/AN/A-
Revenue088.4M-
Total Cash57.9M486M12%
Total Debt051.9M-
FUNDAMENTALS RATINGS
ATOS: Fundamental Ratings
ATOS
OUTLOOK RATING
1..100
5
VALUATION
overvalued / fair valued / undervalued
1..100
22
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ATOSNRIX
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
85%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
78%
Momentum
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
79%
MACD
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
84%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 16 days ago
82%
Declines
ODDS (%)
Bearish Trend 10 days ago
89%
Bearish Trend 5 days ago
89%
BollingerBands
ODDS (%)
N/A
Bullish Trend 2 days ago
81%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
ATOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NRIX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TATYY28.100.50
+1.81%
Tate & Lyle, PLC
CNND190.00N/A
N/A
Canandaigua National Corp.
FMFP11.35N/A
N/A
First Community Financial Corp.
PZAKY17.85N/A
N/A
Powszechny Zaklad Ubezpieczen SA
LMTI0.14N/A
N/A
Laser Master International, Inc.

ATOS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATOS has been loosely correlated with PDSB. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if ATOS jumps, then PDSB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATOS
1D Price
Change %
ATOS100%
+2.18%
PDSB - ATOS
42%
Loosely correlated
-1.64%
MGNX - ATOS
42%
Loosely correlated
+3.09%
NRIX - ATOS
40%
Loosely correlated
+8.66%
KYMR - ATOS
40%
Loosely correlated
+3.10%
RGNX - ATOS
40%
Loosely correlated
+3.08%
More

NRIX and

Correlation & Price change

A.I.dvisor indicates that over the last year, NRIX has been closely correlated with KYMR. These tickers have moved in lockstep 68% of the time. This A.I.-generated data suggests there is a high statistical probability that if NRIX jumps, then KYMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NRIX
1D Price
Change %
NRIX100%
+8.66%
KYMR - NRIX
68%
Closely correlated
+3.10%
IDYA - NRIX
60%
Loosely correlated
+5.15%
DNLI - NRIX
58%
Loosely correlated
+4.33%
CRNX - NRIX
57%
Loosely correlated
+3.97%
BEAM - NRIX
55%
Loosely correlated
+12.62%
More